Shijie Lan

1.0k total citations
36 papers, 647 citations indexed

About

Shijie Lan is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shijie Lan has authored 36 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 9 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shijie Lan's work include Cutaneous Melanoma Detection and Management (4 papers), Nanoplatforms for cancer theranostics (4 papers) and CAR-T cell therapy research (4 papers). Shijie Lan is often cited by papers focused on Cutaneous Melanoma Detection and Management (4 papers), Nanoplatforms for cancer theranostics (4 papers) and CAR-T cell therapy research (4 papers). Shijie Lan collaborates with scholars based in China, United States and Taiwan. Shijie Lan's co-authors include Hao Zhang, Chung‐Cheng Hsieh, Wenjing Wang, Hongchen Sun, I‐Hsuan Su, Bai Yang, Jing Li, Chun‐Yuh Yang, Liang Zhao and Di Wu and has published in prestigious journals such as PLoS ONE, ACS Applied Materials & Interfaces and Journal of Controlled Release.

In The Last Decade

Shijie Lan

35 papers receiving 631 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shijie Lan China 13 236 185 110 108 77 36 647
Xiaofang Guo China 19 215 0.9× 290 1.6× 109 1.0× 139 1.3× 98 1.3× 56 916
Ujjwal Mukund Mahajan Germany 14 394 1.7× 348 1.9× 105 1.0× 82 0.8× 155 2.0× 48 1.1k
Gaoqin Liu China 15 75 0.3× 497 2.7× 174 1.6× 128 1.2× 168 2.2× 46 1.0k
Binita Shrestha United States 15 76 0.3× 227 1.2× 176 1.6× 84 0.8× 224 2.9× 28 803
Liang Hao China 16 71 0.3× 283 1.5× 129 1.2× 45 0.4× 112 1.5× 62 790
Bashir M. Mohamed Ireland 16 148 0.6× 223 1.2× 252 2.3× 290 2.7× 111 1.4× 30 914
Shaohui Huang China 17 161 0.7× 250 1.4× 177 1.6× 149 1.4× 48 0.6× 38 930
Else Marie Huuse Norway 12 61 0.3× 198 1.1× 116 1.1× 52 0.5× 25 0.3× 16 613
Michael Delacher Germany 9 98 0.4× 284 1.5× 164 1.5× 175 1.6× 447 5.8× 17 1.0k

Countries citing papers authored by Shijie Lan

Since Specialization
Citations

This map shows the geographic impact of Shijie Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shijie Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shijie Lan more than expected).

Fields of papers citing papers by Shijie Lan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shijie Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shijie Lan. The network helps show where Shijie Lan may publish in the future.

Co-authorship network of co-authors of Shijie Lan

This figure shows the co-authorship network connecting the top 25 collaborators of Shijie Lan. A scholar is included among the top collaborators of Shijie Lan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shijie Lan. Shijie Lan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lan, Shijie, Sisi Shen, Jiahui Wang, et al.. (2024). Evaluation and Analysis of Traditional Chinese Medicine Treatment of Bovine Viral Diarrhea/Mucosal Disease Based on Network Pharmacology and in vitro Studies. Pharmacognosy Magazine. 21(3). 765–780. 1 indexed citations
3.
Zhang, Mengsi, Lu Wang, Hao Jin, et al.. (2023). Employing single valency polyphenol to prepare metal-phenolic network antitumor reagents through FeOOH assistance. Journal of Controlled Release. 358. 612–625. 20 indexed citations
4.
Lan, Shijie, et al.. (2023). Clinicopathologic Features and Prognosis of Melanoma in Northeast China: A Region-Based Cohort Study of 229 Consecutive Cases. Journal of Investigative Dermatology. 143(11). 2255–2263.e4. 1 indexed citations
5.
Duan, Xiumei, Shuai Wang, Hua He, et al.. (2022). Analysis of molecular pathologic and clinical features of 36 patients with pulmonary sarcomatoid carcinoma. BMC Pulmonary Medicine. 22(1). 453–453. 3 indexed citations
6.
Lan, Shijie, et al.. (2022). A simple method for eyelid reconstruction with an advancement flap after resection of a minor nevus on the eyelid margin. British Journal of Oral and Maxillofacial Surgery. 60(10). 1430–1432. 1 indexed citations
7.
Si, Lu, Xiaoshi Zhang, Yongqian Shu, et al.. (2022). Pembrolizumab in Chinese patients with advanced melanoma: 3-year follow-up of the KEYNOTE-151 study. Frontiers in Immunology. 13. 882471–882471. 18 indexed citations
8.
Zhang, Yiqun, Shijie Lan, & Di Wu. (2022). Advanced Acral Melanoma Therapies: Current Status and Future Directions. Current Treatment Options in Oncology. 23(10). 1405–1427. 16 indexed citations
9.
Wu, Di, et al.. (2020). Renal Pelvis and Renal Calices Sarcomatoid Carcinoma: A Case Report. 1–4. 1 indexed citations
10.
Wang, W., C. Xu, Dawei Wang, et al.. (2020). 1336P Patients with EGFR exon 20 insertion mutation non-small cell lung cancer benefit from pemetrexed-based chemotherapy: A multicenter study. Annals of Oncology. 31. S859–S859. 1 indexed citations
11.
Si, Lu, Xiaoshi Zhang, Yongqian Shu, et al.. (2019). A Phase Ib Study of Pembrolizumab as Second-Line Therapy for Chinese Patients With Advanced or Metastatic Melanoma (KEYNOTE-151). Translational Oncology. 12(6). 828–835. 99 indexed citations
12.
Lan, Shijie, et al.. (2016). Role of GATA-6 and Bone Morphogenetic Protein-2 in Dexamethasone-Induced Cleft Palate Formation in Institute of Cancer Research Mice. Journal of Craniofacial Surgery. 27(6). 1600–1605. 6 indexed citations
13.
Wang, Wenjing, Jing Li, Shijie Lan, et al.. (2016). Seedless synthesis of gold nanorods using resveratrol as a reductant. Nanotechnology. 27(16). 165601–165601. 26 indexed citations
14.
Wu, Di, Weiguo Shi, Jing Zhao, et al.. (2016). Assessment of the chemotherapeutic potential of a new camptothecin derivative, ZBH-1205. Archives of Biochemistry and Biophysics. 604. 74–85. 11 indexed citations
15.
Li, Rong, et al.. (2014). Reconstruction of the Lower Vermilion With a Musculomucosal Flap From the Upper Lip in the Repair of Extensive Lower Lip and Chin Defects. Journal of Craniofacial Surgery. 25(5). 1855–1858. 2 indexed citations
16.
Yue, Jingyin, Huimei Lu, Shijie Lan, et al.. (2013). Identification of the DNA Repair Defects in a Case of Dubowitz Syndrome. PLoS ONE. 8(1). e54389–e54389. 26 indexed citations
17.
Yue, Jingyin, Shijie Lan, Yuan Chang-ji, & Zhiyuan Shen. (2012). Prognostic Values of Filamin-A Status for Topoisomerase II Poison Chemotherapy. International Journal of Biological Sciences. 8(4). 442–450. 8 indexed citations
18.
Lan, Shijie, et al.. (1997). Long-Term Vegetarian Diet and Bone Mineral Density in Postmenopausal Taiwanese Women. Calcified Tissue International. 60(3). 245–249. 91 indexed citations
19.
Hsieh, Chung‐Cheng, María Pavía, Mats Lambe, et al.. (1994). Dual effect of parity on breast cancer risk. European Journal of Cancer. 30(7). 969–973. 68 indexed citations
20.
Yen, Yea‐Yin, et al.. (1990). [Frequency distribution of birth weight and gestational age in Taiwan].. PubMed. 6(4). 186–93. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026